Günther Staffler

2PUBLICATIONS
4CO-AUTHORS
PharmacogenomicsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 10, 2021
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9.

Markus Zeitlinger, Martin Bauer, Roman Reindl-Schwaighofer

|Apr 06, 2019
Antibody-mediated targeting of cleavage-specific OPN-T cell interactions.

Bettina Wanko, Matteo Tardelli, Alexander Jürets

Pageof 1